A new noncommercial, educational campaign, Clinical Trials For All, is being launched to address the lack of awareness around clinical trials that is negatively impacting the health and welfare of people around the world.
“Clinical research isn’t what many people think it is,” said Cinda Orr, founder of SCORR Marketing in a press release. "Patient participation has continued to plague the clinical research industry for too long and research shows that a big reason for this is misunderstanding and awareness. Clinical Trials For All was designed to provide a full range of educational materials from dozens of patients, caregivers, patient advocates, health science organizations, and advocacy groups to help more understand the clinical trial process and how participation might be the right option for you or for a loved one.”
The Clinical Trials For All website consolidates a library of information about clinical trials into one resource and there are ways everyone can join the cause to help increase trial participation and enable greater inclusion in research. Visitors to the website can educate themselves about clinical trials and hear from real patients about their experiences.
Another way to join in the cause is helping spread the word about clinical trials to friends, family, and future patients. The conversation can be joined by using #ClinicalTrialsForAll through Facebook, Instagram, LinkedIn, and X.
Patients, caregivers, patient advocates, health science organizations, and advocacy groups can join Clinical Trials For All as a partner. Current Platinum Partners include Virtue Research and MedVector, as well as a growing list of contributing and participating partners.
New Educational Initiative, Clinical Trials For All, to Drive More Understanding, Participation, and Diversity. (2023, August 22). Business Wire.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.